在动脉样硬化心血管疾病中使用Cystatin C
Siarhei A Dabravolski1, Natalia V Elizova2, Elizaveta R Korchagina3
1Department of Biotechnology Engineering, Braude Academic College of Engineering, Snunit 51, P.O. Box 78, Karmiel 2161002, Israel.
Clinica chimica acta; international journal of clinical chemistry
|November 14, 2025
概括
囊素C (CysC) 是动脉样硬化心血管疾病 (ASCVD) 的一个有前途的生物标志物. 升高的CysC水平预测心血管事件和死亡率,提供超越传统风险因素的价值.
科学领域:
- 生物化学 生物化学
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 动脉样性心血管疾病 (ASCVD) 是全球主要的死亡原因.
- 需要新的生物标志物来增强ASCVD风险分层.
- 囊素C (CysC) 由于其在功能和血管病理生理学中的作用,显示出潜在的潜力.
研究的目的:
- 审查CysC作为ASCVD诊断和预后生物标志物的临床证据.
- 讨论CysC在临床实践中的局限性和未来实施.
主要方法:
- 对横截面研究,前性队列和元分析的综合文献综述.
- 对将CysC水平与ASCVD表现联系起来的研究的评估.
主要成果:
- 升高的CysC与亚临床动脉样硬化严重程度密切相关.
- 高CysC独立预测各种ASCVD条件下的不良心血管事件 (MACE),死亡率和疾病进展.
- 即使在调整传统风险因素和基于肌素的功能估计后,CysC的预后值仍然显著.
结论:
- 赛斯塔丁C是一种强大的生物标志物,在ASCVD中具有显著的诊断和预后效用.
- CysC提供的价值超出其作为功能标志物的作用.
更多相关视频
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
525
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
525
Atherosclerosis III: Management
307
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
377
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
377
Coronary Artery Disease I: Introduction
863
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
863
Atherosclerosis I: Introduction
853
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
853
Cystic Fibrosis: Pathogenesis
693
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
693


